Skip navigation
>»
RSS feed for this page
Know something we don't? Submit a conference announcement
Choose Category:

Research Methods meetings & conferences

53 meetings & conferences listed in Research Methods 

Missing Data in Clinical Trials Forum – The Missing Data in Clinical Trials Forum
United States
Pennsylvania
03/16/2015

Missing Data in Clinical Trials Forum – The Missing Data in Clinical Trials Forum

March 16-17, 2015 Philadelphia, Pennsylvania

A successful clinical trial depends on accurate, high-quality data. However, missing data can significantly compromise all areas of the research, from key inferences made to regulatory compliance. Regulatory bodies have provided relatively little guidance on how to deal with the setbacks caused by missing data. Currently, many studies compensate by means of statistical analysis techniques. While this is a legitimate practice, it is usually not a comprehensive solution, and needs to be used in conjunction with other techniques.

The Missing Data in Clinical Trials Forum is the leading event to help you learn the most cutting-edge strategies to mitigate the effects of missing data in your clinical trials. The mission of this event is to explore the best practices and recent developments not only in adjusting data sets with missing data, but minimizing instances of missing data points in the first place, an area of great interest as the current trend of increasing clinical trial length and complexity continues.

Top Five Reasons to Attend

1. Understand the current state of missing data mitigation and how it impacts life science companies

2. Learn how to eliminate missing data before it happens through better trial design

3. Discover proven insights to increase patient recruitment and retention

4. Master how to monitor and reduce missing data during the conduct of your clinical trials

5. Examine the current regulatory landscape and anticipate future requirements

Who Should Attend

This conference is designed for professionals in the pharmaceutical, medical device or biotechnology industries involved with the following:

• Clinical Operations

• Data/Document Management

• Clinical Quality Management

• Compliance

• Clinical Statistics

• Clinical Trial Monitoring

• Patient Recruitment

• Clinical Data Science

• Medical Research

• Project Management

• Data Analysis

• Strategic R&D Innovations

This event is also of interest to:

• Contract Research Organizations

• Clinical Trial Management Software Providers

• Data Concurrency Service Providers

Pharmaceutical Scientist, Pharmacologist, Physician Researcher, Public Servant
Pan-Omics Summit
United States
Massachusetts
05/21/2015

Pan-Omics Summit

May 21 - 22, 2015 Boston, Massachusetts

The Pan-Omics Summit will take place May 21 - 22, 2015 in Boston, MA at the Hyatt Regency. This summit has four parallel tracks to discuss the developments and challenges in the popular omics areas listed below. Representatives from big pharma, academic institutions, and government research labs will present data on advances in new technology and case studies on therapeutic targets, molecular diagnostics, and integration of complex data.

The Pan-Omics Summit is comprised of these 4 co-located conferences:

5th Next Generation Sequencing

I. Current and Emerging Sequencing Technologies

II. Metagenomics and the Microbiome

III. Leveraging Big Data for Biomedical Discoveries and Applications

IV. Clinical Diagnostic Sequencing

V. RNA Sequencing

VI. Single Cell Genomics

2nd Metabolomics-Advances & Applications in Human Disease

I. Advances in Metabolite Markers

II. Metabolite Identification - Targets and Pathways

III. Computational Approaches to Assessing the Metabolome

IV. Technological Advances in Metabolomics

V. Clinical Applications of Metabolomics

Epigenomics & Novel Therapeutic Targets

I. Transcriptional Regulation

II. Novel Therapeutic Targets and Discovery

III. Pre-Clinical to Clinical Drug Development

IV. New Technological Advances

V. Epigenomic Biomarkers and Diagnostics

VI. Neurological Disorders and Other Diseases

Functional Genomics & Predictive Medicine

I. Molecular Diagnostics & Therapeutic Applications for Complex Human Diseases

II. Understanding Genomic Variation in Three Dimensions: Impact on Protein-Protein and Protein-Drug Interactions

III. Understanding Genomic Variation at the Cellular Level

IV. Approaches for Analyses and Integration of Complex Data

We encourage you to sign up for a summit pass in order to get the most comprehensive look at research, technology, and application in the field of omics. In addition to scientific presentations, dedicated networking sessions will allow you to form connections with numerous representatives from their respective institutions. Please join us for the opportunity to listen to recent updates and share ideas with colleagues. We hope to see you in Boston!

Cell Biologist, Molecular Biologist, Neuroscientist, Pharmaceutical Scientist, Pharmacologist, Physician Researcher
Functional Genomics Conference
United States
Massachusetts
05/21/2015

Functional Genomics Conference

May 21 - 22, 2015 Boston, Massachusetts

We invite you to the attend the Functional Genomics Conference, which will be part of The Pan-Omics Summit to be held May 21 - 22, 2015 in Boston, MA at the Hyatt Regency.

The Functional Genomics Conference focuses on understanding the specific cellular events that occur on every level of transcription, translation, and protein-protein interactions. Speakers will present on mutations that are controlled at the level of DNA and how they are predictors for the change in function and structure in downstream products. Recent developments in gene targeting technology provides crucial information in target validation for therapeutics and application in the areas of inflammation, oncology, immunology, and infectious diseases. Also, we will take a closer look at genomic variation in relation to predicting a patient's response to drugs.

Topics to be discussed:

I. Genomic Variation as a Predictor of Protein-protein and Protein Drug Interactions

II. Molecular Diagnostics and Therapeutic Application for Complex Diseases

III. Transcriptome Profiling and Genome Regulation by mRNAs, microRNAs, and long noncoding RNAs

IV. Approaches for Analysis and Intergration of Complex Data

V. Genome Wide Mutagenesis and Phenotypic Analysis

VI. Developments and Challenges in Target Validation

VII. Prospects for Epigenomic-based Drug Discovery

Molecular Biologist, Pharmaceutical Scientist
5th Next Generation Sequencing Conference
United States
Massachusetts
05/21/2015

5th Next Generation Sequencing Conference

May 21 - 22, 2015 Boston, Massachusetts

We invite you to the attend the 5th Next Generation Sequencing Conference, which will be part of the Pan-Omics Summit to be held May 21 - 22, 2015 in Boston, MA at the Hyatt Regency. This conference aims to gather both industry and academia for a rich exchange of networking and updates in this field.

The 5th Next Generation Sequencing Conference will provide attendees with a better understanding of developments in new next generation sequencing technologies alongside clinical applications. Some key areas of research include nanopore sequencing, sequencing by tunneling, single cell RNA sequencing, all electron sequencing, and data integration.

Cell Biologist, Molecular Biologist, Scientist
2015 Big Data Workshop: Exploring Opportunities for Radiation Oncology
United States
Maryland
08/13/2015

2015 Big Data Workshop: Exploring Opportunities for Radiation Oncology

August 13-14, 2015 NIH Campus, Bethesda, Maryland

ASTRO, the National Cancer Institute (NCI), and the American Association of Physicists in Medicine (AAPM) are co-sponsoring a two-day workshop for radiation oncology physicians and physicists focused on opportunities for radiation oncology in the era of big data.

The 2015 Big Data Workshop: Exploring Opportunities for Radiation Oncology in the Era of Big Data will provide a platform for leaders in big data projects to interact with their peers in radiation oncology research, quality assessment and clinical care. Presentations will include current big data cancer registries, safety and incident reporting systems, and other strategies that will have the greatest impact on radiation oncology research, quality assurance, safety and outcomes analysis/ CRE.

Bioinformatician, Informatician, Oncologist, Physician, Physician Researcher, Radiation Oncologist
2015 International Conference on Brain Informatics and Health
United Kingdom
08/30/2015

2015 International Conference on Brain Informatics and Health

30 August - 2 September 2015 London, United Kingdom

Premier Forum for Brain Informatics

BIH 2015 provides a premier forum that bring together researchers and practitioners from neurosciencce, cognitive science, computer science, data science and neuroimaging technologies with the purpose of exploring the fundamental roles, interactions as well as practical impacts of Brain Informatics. BIH 2015 also include events that focused on Active Media, in order to increase the cross-fertilization of ideas from different communities.

In addition to the main conference, the satellite symposiums and special sessions organized as parts of BIH 2015 will create an opportunity to exchange ideas, identify emerging challenges and present novel results from different domains in a more focused manner.

Computer Scientist, Informatician, Information Scientist, Neuroscientist
Next Generation Sequencing: Towards Single Cell Analysis
Italy
03/10/2015

Next Generation Sequencing: Towards Single Cell Analysis

10th & 11th March 2015 INGM (Instituto Nazionale Genetica Molecolare) Milan, Italy

This Next Generation Sequencing conference highlights the developments of using NGS in the usual application areas such as Epigenetics, Transcriptomics, Exome/Genome Analysis etc whilst moving from analysis of tissues and biofluids towards single cells and limiting amounts of RNA and DNA.

Next Generation Sequencing is a very powerful genomic tool that is opening up new possibilities when it comes to tackling human health issues.  Whether it is the effect of the environment on the DNA (Epigenetics) or the expression of individual genes in single cells (single cell transcriptomics) or the meaning and significance of data from NGS Panels, Exomes or Genomes, researchers are driving the applicability of NGS to its limits.

Biotexcel is partnering with leading genomics institutes in Europe to help push the boundaries by facilitating dialogue and dissemination of knowledge in a way that enables researchers to come together, network and initiate the next generation of collaborations using NGS.

In line with this philosophy Biotexcel is thrilled to announce our partnership with Dr Sergio Abrignani CSO of the National Institute of Molecular Genetics in Italy to hold NGS 2015 Milan: Towards Single Cell Genomic Analysis. NGS Milan 2015 is a gathering not to be missed; it is our virtual R&D ideas hub for those who want to take the limits of NGS further.

WHO SHOULD ATTEND THIS NGS EVENT?

• All NGS users, researchers and students

• Bioinformaticians

• NHS & Private Labs, Biotech Companies, CRO’s, Service Providers
   … and all those interested in the latest developments of:

• Bioinformatics

• Biomarkers

• Computational Biology

• Data Analysis

• Data interpretation

• DNA Sequencing

• Genetics/Genomics

• Infectious and Inherited Diseases

• Informatics

• Molecular and Cell Biology

• Molecular Diagnostics

• Next Generation Sequencing

Academic, Bioinformatician, Biologist, Cell Biologist, Geneticist , Graduate Student, Molecular Biologist, Physician Researcher, Scientist
University College London Qualitative Health Research Symposium 2015
United Kingdom
02/18/2015

University College London Qualitative Health Research Symposium 2015

18th February 2015 London, United Kingdom

Interest in qualitative approaches among academic communities concerned with health and illness is evidenced by the rise of mixed methods studies, the proliferation of qualitative health research journals and conferences, and the marked presence of qualitative researchers in academic centres of health research. This reflects the recognition and endorsement of its contribution to research on health, illness and care. However, its inclusion is not straightforward and there can be tensions between the conceptual and methodological approaches of qualitative research and those of a quantitative paradigm generally more familiar to health practitioners, policymakers and often other researchers. These tensions bring to the fore questions to be explored around the applicability, value, contribution, legitimacy and limitations of qualitative inquiry within the prevailing research culture. Ultimately it raises important questions about how qualitative inquiry can enrich interdisciplinary collaborations.

Aim of symposium

Building on our 2013 qualitative health research meeting, we aim in this 2015 symposium to generate a more focused and constructive commentary on the contributions that qualitative inquiry can make to understandings of health, illness and care.

Academic, Health Services Researcher, Nurse Researcher, Physician Researcher, Public Health Expert
4th World Congress of Dermoscopy and Skin Imaging, IDS 2015
Austria
04/16/2015

4th World Congress of Dermoscopy and Skin Imaging, IDS 2015

April 16–18, 2015 Vienna, Austria

The congress will appropriately consider all aspects of skin imaging, from dermatoscopy to confocal microscopy. The main topics will be amongst others early recognition and treatment of all forms of skin cancer (melanoma and non-melanoma skin cancer) and in vivo imaging of inflammatory skin diseases. Addressing these issues will be a superior faculty of speakers drawn from Europe, the U.S., Canada, South America, Asia, Australia and New Zealand.

Dermatologist, Pathologist, Physician, Physician Researcher
The Human Sciences after the Decade of the Brain--Perspectives on the Neuro-Turn in the Social Sciences and the Humanities
Germany
03/30/2015

The Human Sciences after the Decade of the Brain--Perspectives on the Neuro-Turn in the Social Sciences and the Humanities

March 30 – March 31, 2015 Philosophy Department, Johannes Gutenberg-University of Mainz, Germany

It is now almost 25 years since the U.S. Congress authorized the then president, George Bush sr., to proclaim the decade beginning January 1, 1990 as the Decade of the Brain. This proclamation stimulated a number of initiatives that substantially benefitted neuroscience research in the following years. Alongside this rise of neuroscience and the corresponding increase of public awareness, many disciplines in the humanities and social sciences have shifted towards more brain based and evolutionary informed approaches. New research fields such as Neuroethics, Neuroeconomics, Cognitive Cultural Studies, Neuroaesthetics or even Neurotheology have gained a following. In addition to surveying the mutual interactions between the cognitive neurosciences and the social sciences and humanities, this interdisciplinary conference investigates the methodological and conceptual prospects and perils of choosing a neuroscience approach to the social sciences and the humanities. The conference aims to shed light on a broad range of epistemological, historical and sociological questions about the purported neuro-turn in the social sciences and the humanities including (but not limited to):

• How and why have brain based approaches to the social sciences and humanities developed?

• What exactly distinguishes cognitive and brain based approaches from their traditional counterparts?

• How are brain-based sub-disciplines of the traditional humanities institutionalized?

• How does research policy contribute to the development of a neuro-turn in the social sciences and the humanities?

• Are there common motives for turning to cognitive neuroscience approaches in the different disciplines of social sciences and humanities? If so, which?

• Are there any historical examples of a turn to brain based approaches in the social sciences and the humanities?

• If so, what could be learned from this history for practicing social sciences and humanities today?

• What, if anything, can the humanities and the social sciences learn from the neurosciences?

• What, if anything, can the neurosciences learn from the social sciences and the humanities?

• How does neuroscience change the social sciences and the humanities?

• How do the humanities and the social sciences change neuroscience?

Academic, Historian, Neuroscientist, Philosopher, Social Scientist

23456next